Spotlight on Applicability Domain, Quantitative Potency Assessment and Medical Devices In case you missed SenzaGen’s poster presentations and scientific session at this year’s SOT, we are pleased to offer you a new opportunity to […]
Program 'Introduction to GARDskin (OECD TG 442E) for evaluation of skin sensitization hazard with dose-response option for quantitative risk assessment' Date: 30/05 Session 1: Safety: from irritation to sensitization Presenter: […]
Come meet us at booth #22 and join our presentations to hear the latest news about GARD® and how the assays are used to fill data gaps for skin sensitizing […]
Meet us in Liverpool at the the 11th meeting of Immunotoxicology & Chemical Allergy (ITCASS) and the 30th meeting of European Research Group on Experimental Contact Dermatitis (ERGECD).
Spotlight on in vitro quantitative assessment of skin sensitizing potency. Join our upcoming webinar to explore the recent advancement in GARD® for quantitative assessment of skin sensitizing potency. This session […]
Meet us at Booth #56 Come meet us at booth #56 and join our presentations to hear the latest news about GARD® and how the assays are used to fill […]
Spotlight on Point-of-Departure, Challenging Substances, and Active Ingredients We invite you to join our upcoming webinar, where industry leaders from Lundbeck, Unilever, and Cargill, along with experts from SenzaGen will […]
Meet us at the American Society for Cellular and Computational Toxicology (ASCCT) Annual Meeting in Research Triangle Park, North Carolina. Oral presentation | Monday, 28 October | 17:20-17:35 NAMs […]
Join us for a special re-run of our popular GARD® webinar to explore the recent advancement in Skin Sensitization testing, focusing on substances that fall outside the applicability domains of […]
Join SenzaGen and industry leaders from Clarins and Bic Skin Creative for an in-depth webinar on using GARD® assays for skin sensitization testing. Learn how this innovative technology overcomes the unique challenges […]
